Companies: 10,795·Total market cap: $144.5T
AxoGen, Inc.

AxoGen, Inc.

AXGNNASDAQHealthcare● Active
$42.34
$-0.46(-1.07%)
Market Cap$2.3B
P/E Ratio
52W High$45.83
52W Low$9.22

AxoGen, Inc. (AXGN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

axgn · stock forecast · 19 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 19 Wall Street analysts in the past 3 months

SellBuy

Buy

19 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
16
Hold
3
Sell
0
Strong Sell
0
Total: 19 · Buy rate: 84.2%

12-Month Price Target

High

$50.00

Consensus

$47.00

+10.0% upside

Low

$40.00

Median: $49 · Last Close: $42.74

The AxoGen, Inc. (AXGN) analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month AXGN price target is $47.00, representing +10.0% upside from the current price of $42.74.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $47 (10.0%)

Consensus Target

$47.00

10.0% upside

High Target

$50

17.0%

Low Target

$40

-6.4%

Current Price

$42.74

as of today

Based on analyst price targets, the AXGN stock price prediction for the next 12 months ranges from $40 to $50. The consensus AXGN price forecast of $47.00 implies 10.0% upside from the current price of $42.74.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$43.241.16%

1-day model range: $43.05–$43.43. Peak: $43.43 (+1.16%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$73+70.7%
2028$104+143.1%
2029$130+204.9%
2030$150+251.4%
2031+283.6%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)53.6Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · AXGN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$41.61BUY
MA 10$40.80BUY
MA 20$41.07BUY
MA 50$38.76BUY
MA 100$35.70BUY
MA 200$29.31BUY
Current $AXGN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$41.89BUY
EMA 10$41.38BUY
EMA 20$41.00BUY
EMA 50$39.05BUY
EMA 100$35.89BUY
EMA 200$30.76BUY
Current $AXGN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-04-29
Maintains
BuyBuy
Citizens2026-04-29
Maintains
Market OutperformMarket Outperform
Canaccord Genuity2026-04-29
Maintains
BuyBuy
Wells Fargo2026-04-29
Maintains
OverweightOverweight
Lake Street2026-04-23
Maintains
BuyBuy
Canaccord Genuity2026-03-30
Maintains
BuyBuy
Citizens2026-02-24
Maintains
Market OutperformMarket Outperform
HC Wainwright & Co.2025-12-05
Maintains
BuyBuy
Canaccord Genuity2025-12-05
Maintains
BuyBuy
Jefferies2025-12-04
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on AxoGen, Inc. (AXGN) stock. Of the recent 62 rating actions, 3 were upgrades and 5 were downgrades. 19 analysts currently cover AXGN.

Analyst Recommendation Trends

Buy ratings15↑ +4
Hold ratings00
Sell ratings00

AXGN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 5 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$271M

↓ 28.4% YoY

Revenue Next Year

$319M

↑ 17.6% YoY

EPS This Year

$0.50

EPS Next Year

$0.72

↑ 44.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AXGN EPS of $0.50 for the current fiscal year, based on estimates from 5 analysts. The AXGN revenue forecast is $271M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AXGN stock forecast is supported by two independent data sources: analyst consensus ratings from 19 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AXGN price target is $47.00 (+10.0% upside), with an analyst consensus of Buy.

The AXGN short-term stock prediction for tomorrow is $43.24 (+1.16%). The AXGN stock price prediction for 2027 estimates an average of $73. The AXGN stock prediction for 2030 projects a range of $143–$157.

AxoGen, Inc. trades on NASDAQ under the ticker AXGN. The AXGN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 84% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

AXGN forecast · 8 questions

According to 19 Wall Street analysts, the average 12-month AXGN price target is $47.00, with a high forecast of $50.00 and a low of $40.00. The median price target is shown in the chart above when available. This implies +10.0% potential upside from the current price of $42.74.

AXGN price targetWhat is AXGN price targetAXGN analyst price targetAXGN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.